BioCentury
ARTICLE | Finance

Advising Israel

New Israel Biotech Fund leverages experienced advisory board for investments

July 11, 2016 7:00 AM UTC

A new Israeli VC fund is leveraging a broad base of biopharma advisers to give its portfolio companies an advantage in development, partnering and commercialization activities.

Israel Biotech Fund is raising its first fund, which according to SEC documents is targeting a final close of $100 million. On June 29 the fund made its first investment when it led cancer and dermatology play Vidac Pharma Ltd.'s $9 million series A round. ...